10X Genomics
6230 Stoneridge Mall Road
Pleasanton
CA
94566
United States
115 articles with 10X Genomics
-
Psomagen, Inc. Makes Key Tools and Technologies Accessible and Scalable Through Partnerships With 10x Genomics and Olink Proteomics
1/20/2022
After finalizing partnerships with 10x Genomics and Olink Proteomics in 2021, Psomagen, Inc., is beginning 2022 by bringing end-to-end multiomics solutions to the drug discovery and development, diagnostics, and clinical research industries.
-
10x Genomics to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
12/22/2021
10x Genomics, Inc. (Nasdaq: TXG) today announced the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference.
-
10x Genomics Recognized on The Scientist's Top 10 Innovations List for Fifth Consecutive Year
12/1/2021
10x Genomics, a life sciences leader focused on mastering biology to advance human health, announced that Chromium X has been named one of The Scientist's 2021 Top 10 Innovations, an annual list of newly released products that have the potential to generate the biggest impact on scientific research.
-
This year’s top 30 large and small companies operate in some of the Life Sciences’ hottest spaces – precision medicine, vaccines, gene editing, genomics and oncology.
-
10x Genomics Reports Third Quarter 2021 Financial Results
11/3/2021
10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2021.
-
The life sciences industry continues to be one of the fastest growing industries in the world as the end of the year draws near.
-
10X Genomics is continuing to increase its presence outside of the United States, this time with its first manufacturing facility outside of the country.
-
10x Genomics to Report Third Quarter Financial Results on November 3, 2021
10/7/2021
10x Genomics announced it will report financial results for the third quarter 2021 after market close on Wednesday, November 3rd, 2021.
-
10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
8/31/2021
10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference.
-
10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
8/6/2021
10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit.
-
10x Genomics Reports Second Quarter 2021 Financial Results
8/4/2021
10x Genomics, Inc. reported financial results for the second quarter ended June 30, 2021.
-
10x Genomics to Report Second Quarter Financial Results on August 4, 2021
7/7/2021
10x Genomics announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4th, 2021.
-
Genuity Science Awarded Designation as a 10x Genomics Certified Service Provider in Single Cell Immune Profiling
6/28/2021
Genuity Science, a genomics data, analytics and insights organization, announced its participation with leading life science technology company, 10x Genomics through 10x Genomics' Certified Service Provider program.
-
10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping
6/10/2021
10x Genomics, Inc. announced it is shipping its new Visium Spatial Gene Expression for FFPE assay.
-
10x Genomics to Participate in Upcoming June Investor Conferences
5/24/2021
10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating virtually in the following investor conferences: William Blair 41 st Annual Growth Stock Conference Fireside Chat on Wednesday, June 2 nd at 2:20 p.m. Eastern Time/11:20 p.m. Pacific Time
-
10x Genomics Reports First Quarter 2021 Financial ResultsQ1 2021 revenue growth of 47% over prior year
5/5/2021
10x Genomics, Inc. reported financial results for the first quarter ended March 31, 2021.
-
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
4/29/2021
10x Genomics, Inc., announced the company will be participating in the upcoming BofA Securities 2021 Virtual Healthcare Conference.
-
10x Genomics to Report First Quarter Financial Results on May 5, 2021
4/8/2021
10x Genomics (Nasdaq: TXG) today announced it will report financial results for the first quarter 2021 after market close on Wednesday, May 5th, 2021. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.
-
In a list of the most innovative companies in 2021, Fast Company has outlined 10 biotech companies that continue to revolutionize the drug-discovery landscape.
-
10x Genomics Expands Pleasanton Headquarters with New Facilities at Two Locations
3/9/2021
10x Genomics, Inc. announced expansion plans to support the company’s continued growth in Pleasanton across two properties.